Altria/$MO

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Altria

Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.

Ticker

$MO

Primary listing

NYSE

Employees

6,200

Altria Metrics

BasicAdvanced
$109B
12.55
$5.17
0.57
$4.12
6.54%

What the Analysts think about Altria

Analyst ratings (Buy, Hold, Sell) for Altria stock.

Bulls say / Bears say

Strong demand for its on! nicotine pouches drove Altria to beat second-quarter 2025 revenue and profit estimates, as shipments rose 26.5% and adjusted EPS reached $1.44 versus the $1.39 forecast. (Reuters)
In the first quarter of 2025, Altria topped profit forecasts with adjusted EPS of $1.23 versus $1.19 expected and net revenue of $5.26 billion, underscoring earnings resilience despite a challenging environment. (Reuters)
Altria raised its full-year 2025 adjusted EPS guidance to a range of $5.35–$5.45 per share, up from $5.30–$5.45, signaling management’s confidence in sustainable shareholder returns. (Reuters)
Altria recorded an $873 million non-cash impairment on its NJOY e-cigarette business in Q1 2025 after a patent dispute halted imports, causing a 70% plunge in device shipments and challenging its vaping strategy. (Reuters)
Domestic cigarette shipment volumes in Q2 2025 declined 10.2% year-over-year, highlighting the persistent structural downturn in Altria’s core smokeable products segment. (Reuters)
Unregulated disposable vapes, particularly from China, have eroded Altria’s traditional and smoke-free tobacco businesses, with seizures increasing but delivering limited benefit to the company’s market share. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.

Altria Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Altria Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $MO

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs